New York State Common Retirement Fund
PRVB

New York State Common Retirement Fund’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

New York State Common Retirement Fund’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-34,954
Closed -$842K – 3490
2023
Q1 		$842K Buy
34,954
+45
+0.1% +$565 ﹤0.01% 1930
2022
Q4 		$369K Buy
34,909
+7,701
+28% +$62.1K ﹤0.01% 2463
2022
Q3 		$122K Buy
27,208
+101
+0.4% +$460 ﹤0.01% 2955
2022
Q2 		$108K Sell
27,107
-78
-0.3% -$370 ﹤0.01% 3033
2022
Q1 		$199K Buy
27,185
+35
+0.1% +$209 ﹤0.01% 2823
2021
Q4 		$153K Sell
27,150
-141
-0.5% -$895 ﹤0.01% 2964
2021
Q3 		$175K Sell
27,291
-14,758
-35% -$94.8K ﹤0.01% 2962
2021
Q2 		$354K Buy
42,049
+449
+1% +$3.62K ﹤0.01% 2775
2021
Q1 		$437K Buy
41,600
+2,800
+7% +$39.4K ﹤0.01% 2521
2020
Q4 		$657K Hold
38,800
– – ﹤0.01% 2217
2020
Q3 		$498K Hold
38,800
– – ﹤0.01% 2216
2020
Q2 		$547K Buy
+38,800
New +$490K ﹤0.01% 2158

Other funds holding PRVB

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

New York State Common Retirement Fund's PRVB Position: Q2 2023 in Review

New York State Common Retirement Fund sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 34,954 shares — an estimated $842K sold.

New York State Common Retirement Fund first reported a position in PRVB in Q2 2020 and held it in 12 quarters. The position peaked at $842K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

  • New York State Common Retirement Fund reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • New York State Common Retirement Fund sold 34,954 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $842K.
  • New York State Common Retirement Fund first reported a position in Provention Bio, Inc. Common Stock in Q2 2020 and held it in 12 quarters.
  • New York State Common Retirement Fund's Provention Bio, Inc. Common Stock position peaked at $842K in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on New York State Common Retirement Fund's 13F filing for Q2 2023, filed 7 Aug 2023.